Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
AbCellera Biologics Inc. (ABCL)


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-11-11 Booth Andrew Chief Financial Officer Buy 67,500 $14.71 $993,130 No
2021-11-11 Thermopylae Holdings Ltd. 10%-Owner Buy 202,960 $14.76 $2,995,913 No
2021-09-01 HAMER JOHN Director Sell 300,000 $16.94 $5,082,253 No
2021-06-09 Thermopylae Holdings Ltd. 10%-Owner Sell 5,598,420 $24.03 $134,530,033 No
2021-06-09 Hansen Carl L. G. Chief Executive Officer Sell 6,000,000 $24.13 $144,770,323 No
2021-06-09 Lecault Veronique Chief Operating Officer Sell 1,000,000 $25.50 $25,500,000 No
2021-06-09 Stimart Tryn Chief Legal Officer Sell 1,000,000 $25.50 $25,500,000 No
2021-06-09 Falconer Ester Chief Technology Officer Sell 1,000,000 $25.50 $25,500,000 No
2021-06-09 Booth Andrew Chief Financial Officer Sell 1,200,000 $25.50 $30,600,000 No
2020-12-15 THIEL PETER Director Buy 3,000,000 $20.00 $60,000,000 Yes
2020-12-15 Montalbano John S. Director Buy 25,000 $20.00 $500,000 Yes
2020-12-15 Lecault Veronique Chief Operating Officer Buy 23,000 $20.00 $460,000 Yes
2020-12-15 Hayden Michael R Director Buy 73,665 $20.00 $1,473,300 Yes
2020-12-15 Stimart Tryn Chief Legal Officer Buy 500 $20.00 $10,000 Yes

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?